UBS Group Cuts Bath & Body Works (NYSE:BBWI) Price Target to $17.00

Bath & Body Works (NYSE:BBWI) had its price target cut by UBS Group from $19.00 to $17.00 in a report published on Thursday,Benzinga reports. They currently have a neutral rating on the stock.

Several other research analysts have also recently weighed in on BBWI. Morgan Stanley decreased their target price on Bath & Body Works from $22.00 to $20.00 and set an “equal weight” rating for the company in a research note on Thursday. Piper Sandler started coverage on shares of Bath & Body Works in a research report on Friday, May 15th. They set a “neutral” rating and a $20.00 price objective for the company. The Goldman Sachs Group lowered shares of Bath & Body Works from a “neutral” rating to a “sell” rating and cut their target price for the company from $23.00 to $19.00 in a research note on Wednesday, July 8th. Jefferies Financial Group upped their target price on Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a report on Tuesday, July 28th. Finally, Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, May 27th. Four equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $22.29.

Bath & Body Works Price Performance

Bath & Body Works stock opened at $19.25 on Thursday. The firm has a 50 day simple moving average of $20.30 and a 200-day simple moving average of $19.97. The stock has a market capitalization of $3.88 billion, a PE ratio of 5.01, a price-to-earnings-growth ratio of 1.97 and a beta of 1.38. Bath & Body Works has a 12-month low of $14.27 and a 12-month high of $32.32.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.24 by $0.38. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%.The firm had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.50 billion. The firm’s quarterly revenue was down 2.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.30 earnings per share. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, analysts forecast that Bath & Body Works will post 2.7 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 4.2%. The ex-dividend date of this dividend is Friday, August 21st. Bath & Body Works’s payout ratio is currently 20.83%.

Institutional Investors Weigh In On Bath & Body Works

Several institutional investors and hedge funds have recently modified their holdings of the business. Royal Bank of Canada raised its holdings in Bath & Body Works by 92.8% during the first quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock valued at $1,815,000 after buying an additional 28,815 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in Bath & Body Works by 15.7% during the first quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock valued at $19,586,000 after purchasing an additional 87,529 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Bath & Body Works by 7.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock valued at $17,063,000 after purchasing an additional 36,684 shares during the period. Intech Investment Management LLC acquired a new position in Bath & Body Works during the 1st quarter worth $1,155,000. Finally, Geneos Wealth Management Inc. grew its position in shares of Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Trending Headlines about Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Q2 earnings beat and outlook increase: Bath & Body Works exceeded Wall Street expectations for second-quarter EPS and revenue, supported by stronger direct sales. Management also raised its fiscal 2026 outlook, signaling improving operating momentum and helping drive the stock’s recent advance. BBWI Stock Jumps 7.5% on Q2 Earnings Beat, Fiscal 2026 Outlook Raised
• Positive Sentiment: Above-average call activity: Traders purchased 6,948 call options, 64% above the typical daily volume. The activity may indicate increased near-term bullish interest, although options flow alone does not confirm a change in fundamentals.
• Positive Sentiment: Bullish expectations from some investors: A recent analysis argues that market expectations for Bath & Body Works may be too low, suggesting potential upside if the company continues delivering on its earnings and outlook improvements. Bath & Body Works: Market Expectations Are Set Too Low

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.